Bioequivalency Contamination Generic Drugs Production 
Pharmaceutical Technology
OCTOBER 28, 2022
According to Dr Mansoor Amiji of Northeastern University: “Instead of relying on product quality as a readout after the product is made, you start to implement these procedures into the product production processes. Practising QbD in biosimilar product development.
pharmaphorum
JANUARY 17, 2022
The company was slammed for restricting distribution of its drug so generic drug manufacturers couldn’t conduct bioequivalence tests or access a key ingredient used in the drug’s production. Many people carry the illness but do not exhibit symptoms.
Expert insights. Personalized for you.
130 
Let's personalize your content